Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Wire guide
Process for preparing synthetic intermediates of peripherally-selective inhibitors of dopamine-.beta.-hydroxylase involving catalytic asymmetric hydrogenation
Vehicle drive control system
Image scanner and image forming apparatus
Method and apparatus for blind signal extraction
Automatic engine oil life determination with a factor for oil quality
Device chip carriers, modules, and methods of forming thereof
  Randomly Featured Patents
Lockable tie down
Asymmetric-amplitude dual-polarity charge pump with four-phase selectable operation
Dielectric ceramic compositions based on magnesium, calcium and rare earth metal titanates
Agonist antibody to human thrombopoietin receptor
Device for electrochemical detection or measurement
Indicator panel for vehicle instrument panel and method of manufacture thereof
Hydraulic lifting cylinder-piston unit
Duckbill with cutting teeth
Information processing apparatus and control method thereof
Stick vacuum base